Karyopharm Announces Initiation of a Phase 1 Study of Decitabine (Dacogen) and Selinexor (KPT-330) in Acute Myeloid Leukemia (AML)
April 15, 2014 at 16:06 PM EDT
Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel ...
